Clinical Trials Logo
  1. Home
  2. Gout
  3. NCT02471261
  4. Details
NCT02471261 Clinical Trial

Elastography as Gouty Arthropathy Outcome (EGO)

Gout Clinical Trial

Official title:
Elastography as Gouty Arthropathy Outcome (EGO), a Pilot Study.

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02471261
Other study ID # ESR-14-10146
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 2015
Est. completion date March 2017

Study information
Verified date October 2020
Source Arthritis & Rheumatism Associates, P.C.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Elastography as Gouty Arthropathy Outcome (EGO), a pilot study.

Description:

Pilot study to assess 10 subjects with tophaceous gout on urate lowering therapy or about to begin urate lowering therapy.

Recruitment information / eligibility
Status Completed
Enrollment 10
Est. completion date March 2017
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Subjects who are at least 18 years of age but younger than or equal to 99 years of age. 2. Subjects with gouty arthritis as determined by the ACR 1977 classification criteria for gouty arthritis. 3. Subjects with one palpable tophus detectable by one of the three clinical parameters described. - Exclusion Criteria: 1. Subjects who are not eligible for urate lowering treatment or show a hypersensitivity to these drugs or class of compounds. 2. Subjects with significant cardiovascular, neuropsychiatric, hematologic, hepatic, renal or endocrine dysfunction who in the opinion of the principal investigator are unfit for participation in a clinical trial. 3. Subjects for which the clinical and laboratory assessment would provide undue discomfort and / or are contraindicated. -

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States The Center for Rheumatology and Bone Research Wheaton Maryland

Sponsors (1)
Lead Sponsor Collaborator
Arthritis & Rheumatism Associates, P.C.

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Elastography as Gouty Arthropathy Outcome (EGO), a pilot study Observational trial to measure gouty arthritis changes in subject taking urate lowering therapies 1 year
See also
  Status Clinical Trial Phase
Completed NCT04060173 - A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 Phase 1
Not yet recruiting NCT06187519 - UR+AIMS Gout Wearable Skin Uric Acid Monitor Study N/A
Completed NCT03635957 - Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout Phase 4
Completed NCT04966325 - Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects Early Phase 1
Completed NCT03015948 - A Single Dose Study of SHR4640 in Healthy Male Volunteers Phase 1
Completed NCT02855437 - Novel Methods for Ascertainment of Gout Flares -A Pilot Study N/A
Active, not recruiting NCT02702375 - Meta-analyses of Impotrant Food Sources of Sugars and Incident Cardiometabolic Diseases N/A
Completed NCT01407874 - A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency Phase 2
Completed NCT00985127 - Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout Phase 2
Completed NCT00995618 - Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia Phase 2
Terminated NCT04987294 - Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease Phase 2
Completed NCT03291782 - D-0120 Safety and PK/PD, Food Effect Study in Healthy Volunteers Phase 1
Recruiting NCT03388515 - A Study to Assess the Safety and Tolerability of SSS11 in Healthy Subjects. Phase 1
Completed NCT06189404 - Effect of Tigulixostat on the Pharmacokinetics of Theophylline Phase 1
Enrolling by invitation NCT03336203 - The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF) Phase 4
Recruiting NCT05586958 - Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients Phase 3
Recruiting NCT04047394 - A Study to Determine the Safety, Tolerability, PK and Preliminary PD of SSS11 in Chinese Healthy Adult Volunteers Phase 1
Not yet recruiting NCT05507723 - Tight Control of Gouty Arthritis Compared to Usual Care N/A
Recruiting NCT06056570 - Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia Phase 1/Phase 2
Completed NCT02557126 - Study of URC102 to Assess the Safety and Efficacy in Gout Patients Phase 2